Sympathetic and parasympathetic activity in cancer-related fatigue: More evidence for a physiological substrate in cancer survivors

Psychoneuroendocrinology

Volumn 36, Issue 8, 2011, Pages 1137-1147

  Fagundes, Christopher P ^a   Murray, David M ^b   Hwang, Beom Seuk ^a,b   Gouin, Jean Philippe ^a,b   Thayer, Julian F ^b,c   Sollers, John J ^d   Shapiro, Charles L ^a   Malarkey, William B ^a   Kiecolt Glaser, Janice K ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Autonomic nervous system; Breast cancer; Heart rate variability; Norepinephrine; Respiratory sinus arrhythmia; Vagal tone

Indexed keywords

ANTINEOPLASTIC AGENT; NORADRENALIN;

ADULT; ARTICLE; BREAST CANCER; CANCER FATIGUE; CANCER STAGING; CANCER SURVIVOR; CONTROLLED STUDY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTIDIMENSIONAL FATIGUE SYMPTOM INVENTORY SHORT FORM; PARASYMPATHETIC TONE; PRIORITY JOURNAL; RAND SF 36; RATING SCALE; SOCIAL STRESS; SYMPATHETIC TONE;

ADULT; BREAST NEOPLASMS; CARCINOMA; FATIGUE; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; NOREPINEPHRINE; PARASYMPATHETIC NERVOUS SYSTEM; RESEARCH DESIGN; STRESS, PSYCHOLOGICAL; SURVIVORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 80051469825     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.02.005     Document Type: Article

References (60)

1. Altemus M., Redwine L., Leong Y., Frye C., Porges S., Carter C. Responses to laboratory psychosocial stress in postpartum women. Psychosomatic Medicine 2001, 63:814.
2. Antelmi I., De Paula R., Shinzato A., Peres C., Mansur A., Grupi C. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. The American Journal of Cardiology 2004, 93:381-385.
3. Basco M.R., Krebaum S.R., Rush A.J. Outcome measures of depression. Measuring Patient Changes in Mood, Anxiety, and Personality Disorders 1997, 207-245. American Psychological Association, Washington D.C. H.H. Strupp, L.M. Horowitz, M.J. Lambert (Eds.).
4. Berntson G., Cacioppo J., Quigley K. Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications. Psychophysiology 1993, 30:183-196.
5. Berntson G.G., Cacioppo J.T., Quigley K.S., Fabro V.T. Autonomic space and psychophysiological response. Psychophysiology 1994, 31:44-61.
6. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:1920-1925.
7. Bower J. Behavioral symptoms in patients with breast cancer and survivors. Journal of Clinical Oncology 2008, 26:768.
8. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain, Behavior, and Immunity 2007, 21:863-871.
9. Bower J.E., Ganz P.A., Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosomatic Medicine 2005, 67:277-280.
10. Bower J.E., Ganz P.A., Aziz N., Fahey J.L. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine 2002, 64:604-611.
11. Bower J.E., Ganz P.A., Aziz N., Olmstead R., Irwin M.R., Cole S. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain, Behavior and Immunity 2007, 21:251-258.
12. Bower J.E., Ganz P.A., Desmond K.A., Bernaards C., Rowland J.H., Meyerowitz B.E., Belin T.R. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 2006, 106:751-758.
13. Bower J.E., Ganz P.A., Desmond K.A., Bernaards C.A., Rowland J.H., Meyerowitz B.E., Belin T.R. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 2006, 106:751-758.
14. Bower J.E., Ganz P.A., Desmond K.A., Rowland J.H., Meyerowitz B.E., Belin T.R. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2000, 18:743-753.
15. Bower J.E., Ganz P.A., Dickerson S.S., Petersen L., Aziz N., Fahey J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005, 30:92-100.
16. Brook R., Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. American Journal of Hypertension 2000, 13:112S-122S.
17. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. Journal of Clinical Epidemiology 1994, 47:1245-1251.
18. Cleeland C.S., Bennett G.J., Dantzer R., Dougherty P.M., Dunn A.J., Meyers C.A., Miller A.H., Payne R., Reuben J.M., Wang X.S., Lee B.-N. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003, 97:2919-2925.
19. Collado-Hidalgo A., Bower J.E., Ganz P.A., Cole S.W., Irwin M.R. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clinical Cancer Research 2006, 12:2759-2766.
20. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 2008, 9:46-57.
21. Demark-Wahnefried W., Clipp E.C., McBride C., Lobach D.F., Lipkus I.M., Peterson B.L., Clutter Snyder D., Sloane R., Arbanas J., Kraus W.E. Design of fresh start: a randomized trial of exercise and diet among cancer survivors. Medicine and Science in Sports and Exercise 2003, 35:415-424.
22. Demark-Wahnefried W., Morey M.C., Clipp E.C., Pieper C.F., Snyder D.C., Sloane R., Cohen H.J. Leading the way in exercise and diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors. Controlled Clinical Trials 2003, 24:206-223.
23. Egelund N. Spectral analysis of heart rate variability as an indicator of driver fatigue. Ergonomics 1982, 25:663-672.
24. Folkow B. Physiological aspects of primary hypertension. Physiological Reviews 1982, 62:347.
25. Gamelin F., Berthoin S., Bosquet L. Validity of the polar S810 heart rate monitor to measure RR intervals at rest. Medicine and Science in Sports and Exercise 2006, 38:887.
26. Ganz P.A. Late effects of cancer and its treatment. Seminars in Oncology Nursing 2001, 17:241-248.
27. Ganz P.A., Desmond K.A., Leedham B., Rowland J.H., Meyerowitz B.E., Belin T.R. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. Journal of the National Cancer Institute 2002, 94:39-49.
28. Haensel A., Mills P.J., Nelesen R.A., Ziegler M.G., Dimsdale J.E. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 2008, 33:1305-1312.
29. Hautala A., Tulppo M., Mäkikallio T., Laukkanen R., Nissilä S., Huikuri H. Changes in cardiac autonomic regulation after prolonged maximal exercise. Clinical Physiology 2001, 21:238-245.
30. Kangas M., Bovbjerg D.H., Montgomery G.H. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychological Bulletin 2008, 134:700-741.
31. Kirschbaum C., Pirke K.M., Hellhammer D.H. The "Trier Social Stress Test": a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
32. Kudielka B., Schommer N., Hellhammer D., Kirschbaum C. Acute HPA axis responses, heart rate, and mood changes to psychosocial stress (TSST) in humans at different times of day. Psychoneuroendocrinology 2004, 29:983-992.
33. Lawrence D.P., Kupelnick B., Miller K., Devine D., Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. Journal of the National Cancer Institute Monographs 2004, 32:40-50.
34. Malik M., Bigger J., Camm A., Kleiger R., Malliani A., Moss A., Schwartz P. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93:1043.
35. Mancia G., Grassi G., Giannattasio C., Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999, 34:724.
36. Mark A. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1996, 14:S159.
37. Morrow G. Cancer-related fatigue: causes, consequences, and management. The Oncologist 2007, 12:1.
38. Morrow G., Shelke A., Roscoe J., Hickok J., Mustian K. Management of cancer-related fatigue. Cancer Investigation 2005, 23:229-239.
39. Nolan R.P., Jong P., Barry-Bianchi S.M., Tanaka T.H., Floras J.S. Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review. European Journal of Cardiovascular Prevention and Rehabilitation 2008, 15:386-396.
40. Nunan D., Donovan G., Jakovljevic D.G., Hodges L.D., Sandercock G.R.H., Brodie D.A. Validity and reliability of short-term heart-rate variability from the Polar S810. Medicine and Science in Sports and Exercise 2009, 41:243-250.
41. Park J., Ha M., Yi Y., Kim Y. Subjective fatigue and stress hormone levels in urine according to duration of shiftwork. Journal of Occupational Health 2006, 48:446-450.
42. Porges S.W. Cardiac vagal tone: a physiological index of stress. Neuroscience and Biobehavioral Reviews 1995, 19:225-233.
43. Portenoy R., Itri L. Cancer-related fatigue: guidelines for evaluation and management. The Oncologist 1999, 4:1.
44. Prue G., Rankin J., Allen J., Gracey J., Cramp F. Cancer-related fatigue: a critical appraisal. European Journal of Cancer 2006, 42:846-863.
45. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological, Measurement 1977, 1:385-401.
46. Segerstrom S.C., Nes L.S. Heart rate variability reflects self-regulatory strength, effort, and fatigue. Psychological Science 2007, 18:275-281.
47. Sloan R., Shapiro P., Bagiella E., Bigger J., Lo E., Gorman J. Relationships between circulating catecholamines and low frequency heart period variability as indices of cardiac sympathetic activity during mental stress. Psychosomatic Medicine 1996, 58:25.
48. Smets E., Garssen B., Schuster-Uitterhoeve A., De Haes J. Fatigue in cancer patients. British Journal of Cancer 1993, 68:220.
49. Stein K.D., Jacobsen P.B., Blanchard C.M., Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. Journal of Pain and Symptom Management 2004, 27:14-23.
50. Stein K.D., Martin S.C., Hann D.M., Jacobsen P.B. A multidimensional measure of fatigue for use with cancer patients. Cancer Practice 1998, 6:143-152.
51. Stein P., Bosner M., Kleiger R., Conger B. Heart rate variability: a measure of cardiac autonomic tone. American Heart Journal 1994, 127:1376-1381.
52. Straub R., Härle P. Sympathetic neurotransmitters in joint inflammation. Rheumatic Disease Clinics of North America 2005, 31:43-59.
53. Tak L.M., Riese H., de Bock G.H., Manoharan A., Kok I.C., Rosmalen J.G. As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biological Psychology 2009, 82:101-110.
54. Tarvainen M., Niskanen J., Lipponen J., Ranta-aho P., Karjalainen P. Kubios HRV-A Software for Advanced Heart Rate Variability Analysis 2009, Springer, pp. 1022-1025.
55. Thayer J., Lane R. The role of vagal function in the risk for cardiovascular disease and mortality. Biological Psychology 2007, 74:224-242.
56. Thayer J., Sternberg E. Beyond heart rate variability: vagal regulation of allostatic systems. Annals of the New York Academy of Sciences 2006, 1088:361-372.
57. Tracey K.J. Reflex control of immunity. Nature Reviews Immunology 2009, 9:418-428.
58. Vlcek M., Radikova Z., Penesova A., Kvetnansky R., Imrich R. Heart rate variability and catecholamines during hypoglycemia and orthostasis. Autonomic Neuroscience 2008, 143:53-57.
59. Ware J.E., Sherbourne C.D., Davies A.R. Developing and testing the MOS 20-item short-form health survey: a general population application. Measuring Functioning and Well-Being 1992, Duke University Press, Durham and London. A.L. Stewart, J.E. Ware (Eds.).
60. Wyller V., Saul J., Walløe L., Thaulow E. Sympathetic cardiovascular control during orthostatic stress and isometric exercise in adolescent chronic fatigue syndrome. European Journal of Applied Physiology 2008, 102:623-632.